By Vrinda Manocha (Reuters) - Specialty pharmaceutical company Mallinckrodt Plc said its experimental painkiller significantly reduced the intensity of pain in patients who had undergone a surgical removal of bunions. The drug, MNK-795, showed statistically significant improvement in pain scores over 48 hours, compared to a placebo in a late-stage trial. During the study, subjects took two tablets of MNK-795 every 12 hours. The drug is also designed to resist abuse. The drug is a combination of two older pain drugs acetaminophen and oxycodone. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment